Implantable electrical left ventricular assist systems

Bridge to transplantation and future

Peer M. Portner, Philip E. Oyer, D. Glenn Pennington, William A Baumgartner, Bartley P. Griffith, William R. Frist, Donald J. Magilligan, George P. Noon, Narayanan Ramasamy, Phillip J. Miller, Jal S. Jassawalla

Research output: Contribution to journalArticle

Abstract

An implantable left ventricular assist system (LVAS) utilizing an electromechanically driven dual pusherplate blood pump has been employed in a multiinstitutional trial as a bridge to cardiac transplantation. Under development for permanent circulatory support in patients with end-stage heart disease, the LVAS, in this application, derives power and control from an external console via a percutaneous lead. The LVAS was implanted in 20 patients (16 men, 4 women) who were hemodynamicaliy unstable or in refractory cardiogenic shock. The mean age was 44.9 years (range, 25 to 63 years). Preoperative diagnosis was evenly divided between end-stage ischemic disease, cardiomyopathy, and acute myocardial infarction. Implanted in the left upper quadrant within the anterior abdominal wall, the blood pump was connected between the left ventricular apex and ascending aorta. Total support of the systemic circulation and substantial left ventricular unloading were achieved with synchronous counterpulsation for periods up to 90 days (mean, 22.7 days). All patients were stabilized hemodynamicaliy. The mean preoperative cardiac index of 1.5 L/min/m2 increased by a factor of 2. Pulmonary arterial pressures decreased substantially. Serious complications occurred in 16 patients, precluding cardiac transplantation in 10. Most complications (> 70%) were in patients who did not receive transplants; the most common complication was bleeding. Twelve of 13 patients with LVAS implants for more than seven days were mobilized, and 4 were fully ambulatory and completely rehabilitated. Orthotopic cardiac transplantation was performed in 10 patients after implants ranging from two to 90 days (mean, 30.3 days). Two patients died perioperatively, 1 of presumed sepsis and the other of donor-organ failure. Eight patients who received transplants were discharged and have been followed for 1 to 47 months (mean, 15.9 months). There have been no late deaths: 3 patients are working, 1 is a housewife, and all are in New York Heart Association functional class I. The bridging procedure provides an ideal setting for the initial clinical evaluation of, and offers an encouraging view of, the fully developed permanent LVAS.

Original languageEnglish (US)
Pages (from-to)142-150
Number of pages9
JournalAnnals of Thoracic Surgery
Volume47
Issue number1
DOIs
StatePublished - 1989

Fingerprint

Transplantation
Heart Transplantation
Counterpulsation
Transplants
Cardiogenic Shock
Abdominal Wall
Acute Disease
Cardiomyopathies
Aorta
Heart Diseases
Sepsis
Arterial Pressure
Myocardial Infarction
Tissue Donors
Hemorrhage
Lung

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Portner, P. M., Oyer, P. E., Pennington, D. G., Baumgartner, W. A., Griffith, B. P., Frist, W. R., ... Jassawalla, J. S. (1989). Implantable electrical left ventricular assist systems: Bridge to transplantation and future. Annals of Thoracic Surgery, 47(1), 142-150. https://doi.org/10.1016/0003-4975(89)90256-7

Implantable electrical left ventricular assist systems : Bridge to transplantation and future. / Portner, Peer M.; Oyer, Philip E.; Pennington, D. Glenn; Baumgartner, William A; Griffith, Bartley P.; Frist, William R.; Magilligan, Donald J.; Noon, George P.; Ramasamy, Narayanan; Miller, Phillip J.; Jassawalla, Jal S.

In: Annals of Thoracic Surgery, Vol. 47, No. 1, 1989, p. 142-150.

Research output: Contribution to journalArticle

Portner, PM, Oyer, PE, Pennington, DG, Baumgartner, WA, Griffith, BP, Frist, WR, Magilligan, DJ, Noon, GP, Ramasamy, N, Miller, PJ & Jassawalla, JS 1989, 'Implantable electrical left ventricular assist systems: Bridge to transplantation and future', Annals of Thoracic Surgery, vol. 47, no. 1, pp. 142-150. https://doi.org/10.1016/0003-4975(89)90256-7
Portner, Peer M. ; Oyer, Philip E. ; Pennington, D. Glenn ; Baumgartner, William A ; Griffith, Bartley P. ; Frist, William R. ; Magilligan, Donald J. ; Noon, George P. ; Ramasamy, Narayanan ; Miller, Phillip J. ; Jassawalla, Jal S. / Implantable electrical left ventricular assist systems : Bridge to transplantation and future. In: Annals of Thoracic Surgery. 1989 ; Vol. 47, No. 1. pp. 142-150.
@article{5d45376a42124a62a5465e9c922a1760,
title = "Implantable electrical left ventricular assist systems: Bridge to transplantation and future",
abstract = "An implantable left ventricular assist system (LVAS) utilizing an electromechanically driven dual pusherplate blood pump has been employed in a multiinstitutional trial as a bridge to cardiac transplantation. Under development for permanent circulatory support in patients with end-stage heart disease, the LVAS, in this application, derives power and control from an external console via a percutaneous lead. The LVAS was implanted in 20 patients (16 men, 4 women) who were hemodynamicaliy unstable or in refractory cardiogenic shock. The mean age was 44.9 years (range, 25 to 63 years). Preoperative diagnosis was evenly divided between end-stage ischemic disease, cardiomyopathy, and acute myocardial infarction. Implanted in the left upper quadrant within the anterior abdominal wall, the blood pump was connected between the left ventricular apex and ascending aorta. Total support of the systemic circulation and substantial left ventricular unloading were achieved with synchronous counterpulsation for periods up to 90 days (mean, 22.7 days). All patients were stabilized hemodynamicaliy. The mean preoperative cardiac index of 1.5 L/min/m2 increased by a factor of 2. Pulmonary arterial pressures decreased substantially. Serious complications occurred in 16 patients, precluding cardiac transplantation in 10. Most complications (> 70{\%}) were in patients who did not receive transplants; the most common complication was bleeding. Twelve of 13 patients with LVAS implants for more than seven days were mobilized, and 4 were fully ambulatory and completely rehabilitated. Orthotopic cardiac transplantation was performed in 10 patients after implants ranging from two to 90 days (mean, 30.3 days). Two patients died perioperatively, 1 of presumed sepsis and the other of donor-organ failure. Eight patients who received transplants were discharged and have been followed for 1 to 47 months (mean, 15.9 months). There have been no late deaths: 3 patients are working, 1 is a housewife, and all are in New York Heart Association functional class I. The bridging procedure provides an ideal setting for the initial clinical evaluation of, and offers an encouraging view of, the fully developed permanent LVAS.",
author = "Portner, {Peer M.} and Oyer, {Philip E.} and Pennington, {D. Glenn} and Baumgartner, {William A} and Griffith, {Bartley P.} and Frist, {William R.} and Magilligan, {Donald J.} and Noon, {George P.} and Narayanan Ramasamy and Miller, {Phillip J.} and Jassawalla, {Jal S.}",
year = "1989",
doi = "10.1016/0003-4975(89)90256-7",
language = "English (US)",
volume = "47",
pages = "142--150",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Implantable electrical left ventricular assist systems

T2 - Bridge to transplantation and future

AU - Portner, Peer M.

AU - Oyer, Philip E.

AU - Pennington, D. Glenn

AU - Baumgartner, William A

AU - Griffith, Bartley P.

AU - Frist, William R.

AU - Magilligan, Donald J.

AU - Noon, George P.

AU - Ramasamy, Narayanan

AU - Miller, Phillip J.

AU - Jassawalla, Jal S.

PY - 1989

Y1 - 1989

N2 - An implantable left ventricular assist system (LVAS) utilizing an electromechanically driven dual pusherplate blood pump has been employed in a multiinstitutional trial as a bridge to cardiac transplantation. Under development for permanent circulatory support in patients with end-stage heart disease, the LVAS, in this application, derives power and control from an external console via a percutaneous lead. The LVAS was implanted in 20 patients (16 men, 4 women) who were hemodynamicaliy unstable or in refractory cardiogenic shock. The mean age was 44.9 years (range, 25 to 63 years). Preoperative diagnosis was evenly divided between end-stage ischemic disease, cardiomyopathy, and acute myocardial infarction. Implanted in the left upper quadrant within the anterior abdominal wall, the blood pump was connected between the left ventricular apex and ascending aorta. Total support of the systemic circulation and substantial left ventricular unloading were achieved with synchronous counterpulsation for periods up to 90 days (mean, 22.7 days). All patients were stabilized hemodynamicaliy. The mean preoperative cardiac index of 1.5 L/min/m2 increased by a factor of 2. Pulmonary arterial pressures decreased substantially. Serious complications occurred in 16 patients, precluding cardiac transplantation in 10. Most complications (> 70%) were in patients who did not receive transplants; the most common complication was bleeding. Twelve of 13 patients with LVAS implants for more than seven days were mobilized, and 4 were fully ambulatory and completely rehabilitated. Orthotopic cardiac transplantation was performed in 10 patients after implants ranging from two to 90 days (mean, 30.3 days). Two patients died perioperatively, 1 of presumed sepsis and the other of donor-organ failure. Eight patients who received transplants were discharged and have been followed for 1 to 47 months (mean, 15.9 months). There have been no late deaths: 3 patients are working, 1 is a housewife, and all are in New York Heart Association functional class I. The bridging procedure provides an ideal setting for the initial clinical evaluation of, and offers an encouraging view of, the fully developed permanent LVAS.

AB - An implantable left ventricular assist system (LVAS) utilizing an electromechanically driven dual pusherplate blood pump has been employed in a multiinstitutional trial as a bridge to cardiac transplantation. Under development for permanent circulatory support in patients with end-stage heart disease, the LVAS, in this application, derives power and control from an external console via a percutaneous lead. The LVAS was implanted in 20 patients (16 men, 4 women) who were hemodynamicaliy unstable or in refractory cardiogenic shock. The mean age was 44.9 years (range, 25 to 63 years). Preoperative diagnosis was evenly divided between end-stage ischemic disease, cardiomyopathy, and acute myocardial infarction. Implanted in the left upper quadrant within the anterior abdominal wall, the blood pump was connected between the left ventricular apex and ascending aorta. Total support of the systemic circulation and substantial left ventricular unloading were achieved with synchronous counterpulsation for periods up to 90 days (mean, 22.7 days). All patients were stabilized hemodynamicaliy. The mean preoperative cardiac index of 1.5 L/min/m2 increased by a factor of 2. Pulmonary arterial pressures decreased substantially. Serious complications occurred in 16 patients, precluding cardiac transplantation in 10. Most complications (> 70%) were in patients who did not receive transplants; the most common complication was bleeding. Twelve of 13 patients with LVAS implants for more than seven days were mobilized, and 4 were fully ambulatory and completely rehabilitated. Orthotopic cardiac transplantation was performed in 10 patients after implants ranging from two to 90 days (mean, 30.3 days). Two patients died perioperatively, 1 of presumed sepsis and the other of donor-organ failure. Eight patients who received transplants were discharged and have been followed for 1 to 47 months (mean, 15.9 months). There have been no late deaths: 3 patients are working, 1 is a housewife, and all are in New York Heart Association functional class I. The bridging procedure provides an ideal setting for the initial clinical evaluation of, and offers an encouraging view of, the fully developed permanent LVAS.

UR - http://www.scopus.com/inward/record.url?scp=0024592056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024592056&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(89)90256-7

DO - 10.1016/0003-4975(89)90256-7

M3 - Article

VL - 47

SP - 142

EP - 150

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -